Gan & Lee Pharmaceuticals.
603087
Classificação em ações
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Preço da ação
$10.03
Valor de mercado
$5.99B
Variação (1 dia)
-3.71%
Variação (1 ano)
2.30%
País
CN
Negociar Gan & Lee Pharmaceuticals. (603087)
Categoria
Healthcare
Histórico de dividendos de Gan & Lee Pharmaceuticals. (603087)
Gan & Lee Pharmaceuticals. (símbolo da ação: 603087) realizou um total de 7 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: $3.76
Rendimento de dividendos (TTM): 0.0149
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: $3.76
Rendimento de dividendos (TTM): 0.0149
Pagamentos de dividendos de Gan & Lee Pharmaceuticals. (603087) de 2020 a 2026
Pagamentos anuais de dividendos
| Ano | Dividendo (ajustado para desdobramentos) | Alterar |
|---|---|---|
| 2026 (TTM) | $1.00 | 0.00% |
| 2025 | $1.00 | 42.86% |
| 2024 | $0.7 | 133.33% |
| 2022 | $0.3 | -25.00% |
| 2021 | $0.4 | 12.01% |
| 2020 | $0.3571 | 0.00% |
Lista de todos os pagamentos de dividendos
| Ano | Dividendo | Alterar |
|---|---|---|
| 2026 (TTM) | $1.00 | 0.00% |
| 2025 | $1.00 | 42.86% |
| 2024 | $0.7 | 133.33% |
| 2022 | $0.3 | -25.00% |
| 2021 | $0.4 | 12.01% |
| 2020 | $0.3571 | 0.00% |
Dividendos de empresas semelhantes ou concorrentes
| Empresa | Número de pagamentos de dividendos | País |
|---|---|---|
| 0.00% |
US
|
|
| 27.00% |
FR
|
|
| 52.00% |
JP
|
|
| 175.00% |
US
|
|
| 0.00% |
CH
|
